Repligen Corp. (RGEN)
161.66
-2.14
(-1.31%)
USD |
NASDAQ |
Dec 11, 16:00
161.73
+0.07
(+0.04%)
After-Hours: 20:00
Repligen Cash from Investing (Quarterly): -7.783M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Enovis Corp. | -56.06M |
| Teleflex, Inc. | -767.50M |
| Globus Medical, Inc. | -75.84M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 48.10M |
| Cash from Financing (Quarterly) | -0.239M |
| Free Cash Flow | 103.47M |
| Free Cash Flow Per Share (Quarterly) | 0.7556 |
| Free Cash Flow to Equity (Quarterly) | 39.91M |
| Free Cash Flow to Firm (Quarterly) | 47.79M |
| Free Cash Flow Yield | 1.13% |